Jagoda K Jasielec MD

Assistant Professor of Medicine

5841 S. MARYLAND AVE.Chicago, IL 60637
Phone+1 773-702-8955
Fax+1 773-702-3163

Dr. Jasielec is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Jasielec's full profile Already have an account?

Education & Training

University of ChicagoFellowship, Hematology and Medical Oncology, 2011 - 2014
University of Vermont Medical CenterResidency, Internal Medicine, 2008 - 2011
Jagiellonian University Medical CollegeClass of 2008

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

IL State Medical License 2011 - 2023
VT State Medical License 2008 - 2011

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification Public Health Data Reporter, Medical Research Analytics and Informatics Alliance (MRAIA), 2015-2017
CMS Meaningful Use Stage 2 Certification Public Health Data Reporter, Medical Research Analytics and Informatics Alliance (MRAIA), 2015-2017
CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2015-2017

Publications & Presentations

PubMed

10 citations
Germline predisposition in multiple myeloma.
Fernanda Martins Rodrigues, Jagoda Jasielec, Melody Perpich, Aelin Kim, Luke Moma
Iscience. 2025-01-17
8 citations
Phase 1/2 study of carfilzomib, pomalidomide, and dexamethasone with and without daratumumab in relapsed multiple myeloma.
Benjamin A Derman, Jeffrey Zonder, Donna Reece, Craig Cole, Jesus Berdeja
Blood Advances. 2023-10-10
7 citations
A phase I study of selinexor combined with weekly carfilzomib and dexamethasone in relapsed/refractory multiple myeloma.
Benjamin A Derman, Ajai Chari, Jeffrey Zonder, Ajay Major, Andrew T Stefka
European Journal of Haematology. 2023-05-01

Abstracts/Posters

Selinexor-Containing Regimens for the Treatment of Patients with Multiple Myeloma Refractory to Chimeric Antigen Receptor T-Cell (CAR-T) Therapy
Jagoda K. Jasielec, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Updated Results from an Ongoing Phase 1 Clinical Study of bb21217 Anti-Bcma CAR T Cell Therapy
Jagoda K. Jasielec, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019